Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma

BackgroundGlioblastoma arises from complex interactions between a variety of genetic alterations and environmental perturbations. Little attention has been paid to understanding how genetic variations, altered gene expression and microRNA (miRNA) expression are integrated into networks which act together to alter regulation and finally lead to the emergence of complex phenotypes and glioblastoma.ResultsWe identified association of somatic mutations in 14 genes with glioblastoma, of which 8 genes are newly identified, and association of loss of heterozygosity (LOH) is identified in 11 genes with glioblastoma, of which 9 genes are newly discovered. By gene coexpression network analysis, we indentified 15 genes essential to the function of the network, most of which are cancer related genes. We also constructed miRNA coexpression networks and found 19 important miRNAs of which 3 were significantly related to glioblastoma patients' survival. We identified 3,953 predicted miRNA-mRNA pairs, of which 14 were previously verified by experiments in other groups. Using pathway enrichment analysis we also found that the genes in the target network of the top 19 important miRNAs were mainly involved in cancer related signaling pathways, synaptic transmission and nervous systems processes. Finally, we developed new methods to decipher the pathway connecting mutations, expression information and glioblastoma. We indentified 4 cis-expression quantitative trait locus (eQTL): TP53, EGFR, NF1 and PIK3C2G; 262 trans eQTL and 26 trans miRNA eQTL for somatic mutation; 2 cis-eQTL: NRAP and EGFR; 409 trans- eQTL and 27 trans- miRNA eQTL for lost of heterozygosity (LOH) mutation.ConclusionsOur results demonstrate that integrated analysis of multi-dimensional data has the potential to unravel the mechanism of tumor initiation and progression.

[1]  A. Leonardi,et al.  RbAp48 is a target of nuclear factor-kappaB activity in thyroid cancer. , 2007, The Journal of clinical endocrinology and metabolism.

[2]  A Mingorance,et al.  [Nogo-A functions during the development of the central nervous system and in the adult]. , 2004, Revista de neurologia.

[3]  C. Daub,et al.  BMC Systems Biology , 2007 .

[4]  N. Rajewsky,et al.  Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.

[5]  Anton J. Enright,et al.  Prediction of microRNA targets. , 2007, Drug discovery today.

[6]  A. Leonardi,et al.  RbAp48 is a Target of Nuclear Factor-κB Activity in Thyroid Cancer , 2007 .

[7]  Akhilesh Pandey,et al.  Identification of miR‐21 targets in breast cancer cells using a quantitative proteomic approach , 2009, Proteomics.

[8]  A. Bollen,et al.  Glioblastoma Multiforme: Clinical Findings, Magnetic Resonance Imaging, and Pathology in Five Dogs , 2003, Veterinary pathology.

[9]  Kaichun Wu,et al.  Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. , 2007, Biochemical and biophysical research communications.

[10]  B. Frey,et al.  Using expression profiling data to identify human microRNA targets , 2007, Nature Methods.

[11]  K. Hoang-Xuan,et al.  TP53 codon 72 polymorphism is associated with age at onset of glioblastoma , 2009, Neurology.

[12]  Carel Meijers,et al.  Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems. , 2005, American journal of human genetics.

[13]  G. Turashvili,et al.  Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis , 2007, BMC Cancer.

[14]  Maurice P H M Jansen,et al.  Molecular profiling of platinum resistant ovarian cancer , 2006, International journal of cancer.

[15]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[16]  A. Pardee,et al.  Analysing differential gene expression in cancer , 2003, Nature Reviews Cancer.

[17]  Momiao Xiong,et al.  Generalized T2 test for genome association studies. , 2002, American journal of human genetics.

[18]  A. Ballabio,et al.  MicroRNA target prediction by expression analysis of host genes. , 2009, Genome research.

[19]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[20]  Zhenyu Xuan,et al.  A biochemical approach to identifying microRNA targets , 2007, Proceedings of the National Academy of Sciences.

[21]  Céline Héraud,et al.  Vasoactive intestinal peptide-induced neuritogenesis in neuroblastoma SH-SY5Y cells involves SNAP-25 , 2008, Neuropeptides.

[22]  Yu-Ping Wang,et al.  MiRTif: a support vector machine-based microRNA target interaction filter , 2008, BMC Bioinformatics.

[23]  Tatiana A. Tatusova,et al.  Entrez Gene: gene-centered information at NCBI , 2004, Nucleic Acids Res..

[24]  J. Valcárcel,et al.  Molecular mechanisms of gene expression regulation by the apoptosis-promoting protein TIA-1 , 2001, Apoptosis.

[25]  Matthias Mann,et al.  BASP1 Is a Transcriptional Cosuppressor for the Wilms' Tumor Suppressor Protein WT1 , 2004, Molecular and Cellular Biology.

[26]  Maylis Delugin,et al.  FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients , 2007, Cell Division.

[27]  Gabriele Schackert,et al.  Long-term survival with glioblastoma multiforme. , 2007, Brain : a journal of neurology.

[28]  Christopher Haslett,et al.  Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo , 1999, Nature Medicine.

[29]  Kiyoko F. Aoki-Kinoshita,et al.  KEGG as a glycome informatics resource. , 2006, Glycobiology.

[30]  Manuel Serrano,et al.  miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal , 2010, Cell cycle.

[31]  E. Miska,et al.  MicroRNA—implications for cancer , 2007, Virchows Archiv.

[32]  Bin Zhang,et al.  Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R , 2008, Bioinform..

[33]  Carlo M. Croce,et al.  Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast Differentiation* , 2009, The Journal of Biological Chemistry.

[34]  Molly Megraw,et al.  miRGen: a database for the study of animal microRNA genomic organization and function , 2006, Nucleic Acids Res..

[35]  C. N. Hansen,et al.  Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development , 2009, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[36]  S. Leal,et al.  Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. , 2008, American journal of human genetics.

[37]  S. Browning,et al.  A Groupwise Association Test for Rare Mutations Using a Weighted Sum Statistic , 2009, PLoS genetics.

[38]  Fabio Martelli,et al.  MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3* , 2008, Journal of Biological Chemistry.

[39]  Y. Pekarsky,et al.  Reprogramming of miRNA networks in cancer and leukemia. , 2010, Genome research.

[40]  George A Calin,et al.  An miR-502–Binding Site Single-Nucleotide Polymorphism in the 3′-Untranslated Region of the SET8 Gene Is Associated with Early Age of Breast Cancer Onset , 2009, Clinical Cancer Research.

[41]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[42]  D. Busam,et al.  An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.

[43]  G. Bevilacqua,et al.  NM23 gene expression in human breast carcinomas: Loss of correlation with cell proliferation in the advanced phase of tumor progression , 1997, International journal of cancer.

[44]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[45]  P Joyce,et al.  The distribution of rare alleles , 1995, Journal of mathematical biology.

[46]  Artemis G. Hatzigeorgiou,et al.  Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer , 2008, Proceedings of the National Academy of Sciences.

[47]  Anthony R. Dallosso,et al.  Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. , 2008, Cancer research.

[48]  D.,et al.  Regression Models and Life-Tables , 2022 .

[49]  Alberto Riva,et al.  Kaposi's Sarcoma-Associated Herpesvirus Encodes an Ortholog of miR-155 , 2007, Journal of Virology.

[50]  A. Hatzigeorgiou,et al.  TarBase: A comprehensive database of experimentally supported animal microRNA targets. , 2005, RNA.

[51]  A Mingorance,et al.  Funciones de Nogo-A durante el desarrollo del sistema nervioso central y en el animal adulto , 2004 .

[52]  A. Beyer,et al.  Detection and interpretation of expression quantitative trait loci (eQTL). , 2009, Methods.

[53]  Nahum Sonenberg,et al.  A Novel Function of the MA-3 Domains in Transformation and Translation Suppressor Pdcd4 Is Essential for Its Binding to Eukaryotic Translation Initiation Factor 4A , 2004, Molecular and Cellular Biology.

[54]  Sophia Tsoka,et al.  Robustness of the p53 network and biological hackers , 2005, FEBS letters.

[55]  Thomas Manke,et al.  Robustness and network evolution--an entropic principle , 2005 .

[56]  A. Sparks,et al.  The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.

[57]  Pei Wang,et al.  Partial Correlation Estimation by Joint Sparse Regression Models , 2008, Journal of the American Statistical Association.

[58]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[59]  D J Hussey,et al.  The (4;11)(q21;p15) translocation fuses the NUP98 and RAP1GDS1 genes and is recurrent in T-cell acute lymphocytic leukemia. , 1999, Blood.

[60]  Paul S Mischel,et al.  Molecular Analysis of Glioblastoma: Pathway Profiling and Its Implications for Patient Therapy , 2003, Cancer biology & therapy.

[61]  R. Tothill,et al.  Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors , 2008, Molecular Cancer Research.

[62]  Sung-Liang Yu,et al.  MicroRNA signature predicts survival and relapse in lung cancer. , 2008, Cancer cell.

[63]  An-Yuan Guo,et al.  A Novel microRNA and transcription factor mediated regulatory network in schizophrenia , 2010, BMC Systems Biology.

[64]  Paul Ahlquist,et al.  MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins , 2008, Proceedings of the National Academy of Sciences.

[65]  Nan Li,et al.  A Novel Endogenous Human CaMKII Inhibitory Protein Suppresses Tumor Growth by Inducing Cell Cycle Arrest via p27 Stabilization* , 2008, Journal of Biological Chemistry.

[66]  Liu Hong,et al.  Calcyclin-Binding Protein Inhibits Proliferation, Tumorigenicity, and Invasion of Gastric Cancer , 2007, Molecular Cancer Research.

[67]  Jin Namkoong,et al.  Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. , 2007, Cancer research.

[68]  R. Foà,et al.  Molecular evaluation of the NUP98/RAP1GDS1 gene frequency in adults with T-acute lymphoblastic leukemia. , 2001, Haematologica.

[69]  R. Tibshirani,et al.  Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" , 2007, Science.

[70]  K. Moore,et al.  MiR-33 Contributes to the Regulation of Cholesterol Homeostasis , 2010, Science.

[71]  E Soeda,et al.  Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE superclass, in ovarian cancer cell lines. , 2000, Biochemical and biophysical research communications.

[72]  Guy Cavet,et al.  Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" , 2007, Science.